Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by GlobeNewswire
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
99
100
Next >
Rekor Systems Announces Strategic On-Shoring of Overseas Engineering Operations to Advance Cost Discipline and Operational Efficiency
February 24, 2026
From
Rekor Systems
Via
GlobeNewswire
Tickers
REKR
Giant Containers Retained to Design, Deliver New Modular Structures for World-Leading EV Company
February 24, 2026
From
Olenox Industries Inc.
Via
GlobeNewswire
Tickers
OLOX
Applied Materials Awards Suppliers for Outstanding Performance
February 24, 2026
From
Applied Materials, Inc.
Via
GlobeNewswire
Tickers
AMAT
Alveus Therapeutics Announces Second and Final Closing of Oversubscribed Series A, Bringing Total Financing to $197 Million to Advance Next‑Generation Therapies for Obesity and Metabolic Diseases
February 24, 2026
From
Alveus Therapeutics Inc
Via
GlobeNewswire
ADW Capital Management Sends Letter to Compass Diversified’s Board Calling for an Immediate Strategic Review Process and Orderly Liquidation of the Company
February 24, 2026
From
ADW Capital Management, LLC
Via
GlobeNewswire
Tickers
CODI
PTLE Announces 1-for-80 Share Consolidation
February 24, 2026
From
PTL Limited
Via
GlobeNewswire
Tickers
PTLE
GDS Announces Adjournments of Extraordinary General Meeting and Additional Shareholders Meetings to be Reconvened on March 10, 2026
February 24, 2026
From
GDS Holdings Limited
Via
GlobeNewswire
Tickers
GDS
Learning Tree International Awarded Multi-Year Sole-Award NATO NCIA Commercial Training Services Contract – IFB-CO-423236
February 24, 2026
From
Learning Tree International USA, Inc
Via
GlobeNewswire
Xometry Reports Record Fourth Quarter and Strong Full Year 2025 Results
February 24, 2026
From
Xometry, Inc.
Via
GlobeNewswire
Tickers
XMTR
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
February 24, 2026
From
Apellis Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
APLS
Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference
February 24, 2026
From
Treace Medical Concepts, Inc.
Via
GlobeNewswire
Tickers
TMCI
Xometry Announces CEO Succession Plan
February 24, 2026
From
Xometry, Inc.
Via
GlobeNewswire
Tickers
XMTR
New WJ V Nonverbal Cognitive Assessment from Riverside Insights Closes Critical Gap in Student Evaluation
February 24, 2026
From
Riverside Insights
Via
GlobeNewswire
New Publication Demonstrates Variant-Agnostic Correlate of Protection from COVID-19 for Invivyd Monoclonal Antibody, Useful for Understanding of and Confidence in COVID-19 Antibodies
February 24, 2026
From
Invivyd
Via
GlobeNewswire
Tickers
IVVD
Beam Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Announces New Liver-Targeted Genetic Disease Program in Phenylketonuria (PKU)
February 24, 2026
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
February 24, 2026
From
Fulcrum Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FULC
Shoals Technologies Group, Inc. Reports Financial Results for Fourth Quarter 2025
February 24, 2026
From
Shoals Technologies Group
Via
GlobeNewswire
Tickers
SHLS
Arvinas Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
February 24, 2026
From
Arvinas Inc.
Via
GlobeNewswire
Tickers
ARVN
Garrett Motion Announces Participation at the Bank of America Global Automotive Summit
February 24, 2026
From
Garrett Motion Inc.
Via
GlobeNewswire
Tickers
GTX
Monte Rosa Therapeutics Presents Updated Clinical Data from Phase 1/2 Study of MRT-2359 in Combination with Enzalutamide in Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer Patients at ASCO Genitourinary Cancers Symposium (ASCO GU)
February 24, 2026
From
Monte Rosa Therapeutics, Inc.
Via
GlobeNewswire
Tickers
GLUE
OTC Markets Group Welcomes Nations Royalty Corp. to OTCQX
February 24, 2026
From
OTC Markets
Via
GlobeNewswire
Tickers
NRYCF
OTCM
TSX-V:NRC
Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences
February 24, 2026
From
Foghorn Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FHTX
Atea Pharmaceuticals Presents Preclinical Results Supporting First-in-Class Potential of AT-587 for Treatment of Hepatitis E Virus at CROI 2026
February 24, 2026
From
Atea Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
AVIR
Balchem Corporation to Participate in the JP Morgan Consumer Ingredients Forum on March 10, 2026
February 24, 2026
From
Balchem Corporation
Via
GlobeNewswire
Tickers
BCPC
OROCO COMMENCES PHASE 2 DRILLING
February 24, 2026
From
Oroco Resource Corp.
Via
GlobeNewswire
Tickers
ORRCF
TSX-V:OCO
Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results
February 24, 2026
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Sotera Health Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 Outlook
February 24, 2026
From
Sotera Health Services, LLC
Via
GlobeNewswire
Tickers
SHC
Cipher Digital Provides Fourth Quarter and Full Year 2025 Business Update
February 24, 2026
From
Cipher Digital Inc.
Via
GlobeNewswire
Tickers
CIFR
CIFRW
Cullinan Therapeutics to Participate in Upcoming Investor Conferences
February 24, 2026
From
Cullinan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CGEM
Fulcrum Therapeutics Announces Positive 12-Week Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
February 24, 2026
From
Fulcrum Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FULC
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.